
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11342387
[patent_doc_number] => 09526773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'M. tuberculosis vaccines'
[patent_app_type] => utility
[patent_app_number] => 14/437998
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13212
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437998 | M. tuberculosis vaccines | Oct 17, 2013 | Issued |
Array
(
[id] => 10162554
[patent_doc_number] => 09193771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Neurotoxins exhibiting shortened biological activity'
[patent_app_type] => utility
[patent_app_number] => 14/056247
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5982
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14056247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/056247 | Neurotoxins exhibiting shortened biological activity | Oct 16, 2013 | Issued |
Array
(
[id] => 9435398
[patent_doc_number] => 20140113305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'EXOSOMES AND DIAGNOSTIC BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 14/052378
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14833
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052378
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052378 | Exosomes and diagnostic biomarkers | Oct 10, 2013 | Issued |
Array
(
[id] => 9408085
[patent_doc_number] => 20140099337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'Pneumococcal Vaccine and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/049842
[patent_app_country] => US
[patent_app_date] => 2013-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22394
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14049842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/049842 | Pneumococcal vaccine and uses thereof | Oct 8, 2013 | Issued |
Array
(
[id] => 9330125
[patent_doc_number] => 20140056906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'SECRETED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/048277
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48866
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048277
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/048277 | Antibody to secreted polypeptide | Oct 7, 2013 | Issued |
Array
(
[id] => 11356395
[patent_doc_number] => 09533034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Vaccine for intrauterine disease'
[patent_app_type] => utility
[patent_app_number] => 14/647623
[patent_app_country] => US
[patent_app_date] => 2013-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11752
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647623
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647623 | Vaccine for intrauterine disease | Oct 7, 2013 | Issued |
Array
(
[id] => 9283403
[patent_doc_number] => 20140033371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'SULFONYLUREA-RESPONSIVE REPRESSOR PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/045087
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 49636
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045087
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045087 | SULFONYLUREA-RESPONSIVE REPRESSOR PROTEINS | Oct 2, 2013 | Abandoned |
Array
(
[id] => 10110053
[patent_doc_number] => 09145456
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-09-29
[patent_title] => 'Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis'
[patent_app_type] => utility
[patent_app_number] => 14/036102
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10493
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/036102 | Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis | Sep 24, 2013 | Issued |
Array
(
[id] => 9396104
[patent_doc_number] => 20140093510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'CHLAMYDIA ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/035750
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35673
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14035750
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/035750 | Chlamydia antigens | Sep 23, 2013 | Issued |
Array
(
[id] => 10863454
[patent_doc_number] => 08889145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Immunogenic compositions of Staphylococcus aureus antigens'
[patent_app_type] => utility
[patent_app_number] => 14/032534
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 41111
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032534
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/032534 | Immunogenic compositions of Staphylococcus aureus antigens | Sep 19, 2013 | Issued |
Array
(
[id] => 13104991
[patent_doc_number] => 10071124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Treatment of post-traumatic stress disorder with isolated
[patent_app_type] => utility
[patent_app_number] => 14/429697
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6876
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429697
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429697 | Treatment of post-traumatic stress disorder with isolated | Sep 16, 2013 | Issued |
Array
(
[id] => 9435410
[patent_doc_number] => 20140113317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'POLYCLONAL ANTIBODIES TO CLONED FUNGAL POLYPEPTIDE TARGETS'
[patent_app_type] => utility
[patent_app_number] => 14/028670
[patent_app_country] => US
[patent_app_date] => 2013-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4659
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028670
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028670 | POLYCLONAL ANTIBODIES TO CLONED FUNGAL POLYPEPTIDE TARGETS | Sep 16, 2013 | Abandoned |
Array
(
[id] => 9222435
[patent_doc_number] => 20140017210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'METHODS FOR REGULATING GELATION OF POLYSACCHARIDE SOLUTIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/028080
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14423
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028080
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028080 | METHODS FOR REGULATING GELATION OF POLYSACCHARIDE SOLUTIONS AND USES THEREOF | Sep 15, 2013 | Abandoned |
Array
(
[id] => 10340691
[patent_doc_number] => 20150225692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'PROGRAMMABLE DRUG DELIVERY PROFILES OF TUMOR-TARGETED BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 14/428341
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 54686
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428341
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428341 | Programmable drug delivery profiles of tumor-targeted bacteria | Sep 12, 2013 | Issued |
Array
(
[id] => 10013902
[patent_doc_number] => 09056912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Immunogenic compositions for Streptococcus pyogenes'
[patent_app_type] => utility
[patent_app_number] => 14/021128
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29882
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/021128 | Immunogenic compositions for Streptococcus pyogenes | Sep 8, 2013 | Issued |
Array
(
[id] => 11342391
[patent_doc_number] => 09526776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Combination vaccines with serogroup B meningococcus and D/T/P'
[patent_app_type] => utility
[patent_app_number] => 14/420238
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 31547
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420238
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420238 | Combination vaccines with serogroup B meningococcus and D/T/P | Sep 5, 2013 | Issued |
Array
(
[id] => 10306512
[patent_doc_number] => 20150191513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 14/420937
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15430
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420937
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420937 | STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS | Aug 28, 2013 | Abandoned |
Array
(
[id] => 11574663
[patent_doc_number] => 09629905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-25
[patent_title] => 'Neisseria meningitidis fHbp variant and its use for vaccination'
[patent_app_type] => utility
[patent_app_number] => 14/423047
[patent_app_country] => US
[patent_app_date] => 2013-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 6737
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423047
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/423047 | Neisseria meningitidis fHbp variant and its use for vaccination | Aug 21, 2013 | Issued |
Array
(
[id] => 10346217
[patent_doc_number] => 20150231223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'IMMUNOGENIC COMPOSITION OF KILLED LEPTOSPIRA BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 14/420946
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3256
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420946 | Immunogenic composition of killed leptospira bacteria | Aug 15, 2013 | Issued |
Array
(
[id] => 9222496
[patent_doc_number] => 20140017270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'SMALL STREPTOCOCCUS PYOGENES ANTIGENS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/967657
[patent_app_country] => US
[patent_app_date] => 2013-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28477
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967657
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967657 | SMALL STREPTOCOCCUS PYOGENES ANTIGENS AND THEIR USE | Aug 14, 2013 | Abandoned |